What does ALL stand for?

Acute Lymphoblastic Leukemia

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Automatic Lexical Knowledge Base (Columbia University) Assistance League of Kansas City (Missouri) A Little Knowledge Is A Dangerous Thing Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausarzte (German: Association of Leading Cardiological Hospital Physicians) Almighty Latin King Nation (street gang) Alkaline Phosphatase Almighty Latin King and Queen Nation Alkermes, Inc. (stock symbol) Alkalinity (chemistry) Acute Lymphatic Leukemia		Acute Lymphocytic Leukemia Adams-Millis Corporation (former NYSE symbol; now delisted) Address Locator Logic Adult Learning and Literacy (various organizations) Adult Literacy League (Orlando, FL) Airborne Laser Laboratory Aircraft Landing Lamp Albanian Lek (currency code) All Living Legends (Oslo, Norway gaming group) Allee (German: alley)

Samples in periodicals archive:

Clolar already is approved for a form of the disease called acute lymphoblastic leukemia in patients younger than 21 years old.

FDA: problems with Genzyme study of leukemia drug

Clolar already is approved for a form of the disease called acute lymphoblastic leukemia in patients younger than 21 years old.

FDA: problems with Genzyme study of leukemia drug

Jude Children's Research Hospital have identified inherited variations in two genes that can lead to childhood acute lymphoblastic leukemia (ALL), a common childhood cancer.

Two new genetic variations linked to common childhood cancer

Acute lymphoblastic leukemia (ALL) is a neoplastic disorder that is rapidly fatal if untreated.

Acute pancreatitis induced by adult precursor B-cell acute ...

17 in honor of their son, Emilio, who was diagnosed with acute lymphoblastic leukemia at age 3 and lost his battle with the disease at age 5.

The Emilio Nares Foundation, founded by Richard and Diane Nares, ...

The hospital's self-study, conducted over two months in 2005, involved children diagnosed with acute lymphoblastic leukemia, the most common malignancy diagnosed in children.

Study: 1-in-5 chance of error in kids' cancer drugs

has initiated a Phase I/II clinical trial of Fodosine(TM) (forodesine hydrochloride), the company's lead anti-cancer compound, to determine the safety of repeat doses of an intravenous (IV) formulation of the drug in patients with B-cell acute lymphoblastic leukemia (B-ALL).

BIOCRYST INITIATES INTRAVENOUS PHASE I/II OF FODOSINE

The company expects approval in the treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL).

Novartis Pharma Files Applicaion Seeking Additional Indication for ...